Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Laura Marchbank"'
Autor:
Suzanne M Lloyd, David J Stott, Anton J M de Craen, Patricia M Kearney, Naveed Sattar, Ivan Perry, Christopher J Packard, Andrew Briggs, Laura Marchbank, Harry Comber, J Wouter Jukema, Rudi G J Westendorp, Stella Trompet, Brendan M Buckley, Ian Ford
Publikováno v:
PLoS ONE, Vol 8, Iss 9, p e72642 (2013)
The PROspective Study of Pravastatin in the Elderly at Risk (PROSPER), a placebo-controlled trial of pravastatin, demonstrated a 19% reduction in coronary outcomes (p=0.006) after a mean of 3.2 years, with no impact on stroke outcomes or all-cause mo
Externí odkaz:
https://doaj.org/article/1f2629ed3a204cf4a3af1f2e756f1923
Autor:
Anton J. M. de Craen, Laura Marchbank, Andrew Briggs, Suzanne M. Lloyd, Brendan M. Buckley, Ivan J. Perry, Ian Ford, Harry Comber, Naveed Sattar, Patricia M. Kearney, Stella Trompet, David J. Stott, Chris J. Packard, J. Wouter Jukema, Rudi G. J. Westendorp
Publikováno v:
PLoS ONE
PLoS ONE, 8(9)
PLoS ONE, Vol 8, Iss 9, p e72642 (2013)
PLoS ONE, 8(9)
PLoS ONE, Vol 8, Iss 9, p e72642 (2013)
Background:\ud \ud The PROspective Study of Pravastatin in the Elderly at Risk (PROSPER), a placebo-controlled trial of pravastatin, demonstrated a 19% reduction in coronary outcomes (p = 0.006) after a mean of 3.2 years, with no impact on stroke out
Autor:
Ian Ford, Alex McConnachie, Chris J. Packard, Laura Marchbank, Andrew Walker, Michele Robertson, Julie Peacock, Stuart M. Cobbe
Publikováno v:
European Heart Journal
Aims: To assess the impact on healthcare resource utilization, costs, and quality of life over 15 years from 5 years of statin use in men without a history of myocardial infarction in the West of Scotland Coronary Prevention Study (WOSCOPS).\ud \ud M